BioScience Communications, a division of Daniel J. Edelman, Inc., is a trusted partner to biopharma, medical device, and emerging science companies worldwide. Since its founding in 1995, BioScience has grown and evolved in tandem with the changing healthcare and regulatory environment and extraordinary research and technologic advances. We have continued to adapt and expand our core medical communications, science writing, and creative capabilities, and have developed expertise across the range of established and emerging therapeutic categories. Clients consistently give us high marks for strategic counsel, scientific depth, creative solutions, and flawless execution – all with careful attention to compliance. Our high retention rate among senior personnel reflects a positive work environment and the stability of service essential to quality work. Follow us on twitter at bioscicom